Santa Cruz Biotechnology provides a broad selection of Influenza A m2 monoclonal antibodies for research in virology and immunology. Influenza A m2 monoclonal antibodies are highly useful in various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The Influenza A m2 protein plays a critical role in the viral life cycle, functioning as an ion channel that facilitates the acidification of the viral interior, which is essential for viral uncoating and replication. Understanding the mechanisms of Influenza A m2 protein is vital for developing antiviral strategies and vaccines, as it is a key target for therapeutic intervention. The study of Influenza A m2 protein can provide valuable insights into the pathogenesis of influenza and the host immune response. Research using Influenza A m2 monoclonal antibodies has led to significant discoveries in viral entry mechanisms and potential therapeutic targets. Investigating Influenza A m2 protein function has enhanced our understanding of viral pathogenesis and host-pathogen interactions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge and developing innovative solutions for viral diseases.